Microbiome risk profiles as biomarkers for inflammatory and metabolic disorders

Keyphrases

• Risk Profile 100%
• Gut Microbiota 100%
• Microbiome 100%
• Metabolic Disorders 100%
• Inflammatory Disorders 100%
• Omics Technologies 66%
• Host Response 33%
• Inflammatory Bowel Disease 33%
• Type 2 Diabetes Mellitus (T2DM) 33%
• High-throughput 33%
• Omics Data 33%
• Mechanistic Understanding 33%
• Going beyond 33%
• Metabolomics 33%
• Microorganisms 33%
• Microbes 33%
• Intestine 33%
• Bacterial Products 33%
• Microbial Dysbiosis 33%
• Microbiota 33%
• Microbial Community Structure 33%
• Metagenomics 33%
• Bacterial Isolates 33%
• Host Signals 33%
• Intestinal Health 33%
• Disease Evolution 33%
• Human Pathology 33%
• Microbial Signatures 33%
• Incomplete Understanding 33%
• Evolution Understanding 33%
• Disease Causation 33%
• Heterogeneity of Microbial Community 33%
• Rapid Innovation 33%

Medicine and Dentistry

• Biological Marker 100%
• Disease 100%
• Inflammatory Disorder 100%
• Gut Microbiota 100%
• Water-Electrolyte Imbalance 100%
• Microbiome 100%
• Tamsulosin 100%
• Immune Response 33%
• Disease Course 33%
• Metabolomics 33%
• Maturity Onset Diabetes of the Young 33%
• Dysbiosis 33%
• Inflammatory Bowel Disease 33%
• Intestine 33%
• Signal Transduction 33%

Immunology and Microbiology

• Multi-Omics 100%
• Microbiome 100%
• Intestine Flora 100%
• Microorganism 66%
• Metagenomics 33%
• Intestine 33%
• Microflora 33%
• Immune Response 33%
• Signal Transduction 33%
• Inflammatory Bowel Disease 33%